Free Trial

UBS Group Issues Positive Forecast for Equifax (NYSE:EFX) Stock Price

Equifax logo with Business Services background

Key Points

  • UBS Group has raised its price target for Equifax stock from $287.00 to $297.00, indicating a potential upside of 15.81% from current levels, and maintains a "buy" rating.
  • Other analysts show mixed opinions, with Bank of America lowering their rating to "neutral" and setting a target of $285.00, while Morgan Stanley and Royal Bank of Canada reaffirm strong ratings and targets of $305.00 and $300.00, respectively.
  • Equifax reported earnings of $2.00 per share for the last quarter, surpassing expectations, and has set its Q3 2025 guidance at 1.870-1.970 EPS for future performance estimates.
  • Interested in Equifax? Here are five stocks we like better.

Equifax (NYSE:EFX - Get Free Report) had its price objective increased by equities researchers at UBS Group from $287.00 to $297.00 in a research report issued on Monday,Benzinga reports. The firm currently has a "buy" rating on the credit services provider's stock. UBS Group's price target indicates a potential upside of 15.81% from the stock's current price.

Other analysts have also issued research reports about the stock. Bank of America lowered shares of Equifax from a "buy" rating to a "neutral" rating and dropped their price target for the stock from $300.00 to $285.00 in a research note on Monday, June 23rd. Morgan Stanley restated an "overweight" rating and issued a $305.00 target price (up previously from $295.00) on shares of Equifax in a research note on Tuesday, June 10th. Wells Fargo & Company decreased their price target on Equifax from $310.00 to $300.00 and set an "overweight" rating for the company in a research note on Wednesday, July 23rd. Robert W. Baird cut their price objective on Equifax from $310.00 to $289.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 23rd. Finally, Royal Bank Of Canada reiterated an "outperform" rating and issued a $300.00 price target on shares of Equifax in a report on Wednesday, June 18th. One research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, Equifax presently has a consensus rating of "Moderate Buy" and a consensus target price of $284.80.

Get Our Latest Research Report on Equifax

Equifax Stock Performance

Equifax stock opened at $256.46 on Monday. The firm has a market capitalization of $31.75 billion, a PE ratio of 50.19, a price-to-earnings-growth ratio of 3.09 and a beta of 1.68. The stock's 50 day moving average price is $249.19 and its 200 day moving average price is $250.33. The company has a debt-to-equity ratio of 0.79, a quick ratio of 0.77 and a current ratio of 0.77. Equifax has a one year low of $199.98 and a one year high of $309.63.

Equifax (NYSE:EFX - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The credit services provider reported $2.00 earnings per share for the quarter, beating analysts' consensus estimates of $1.92 by $0.08. Equifax had a net margin of 10.95% and a return on equity of 18.89%. The company had revenue of $1.54 billion during the quarter, compared to analysts' expectations of $1.51 billion. During the same period in the prior year, the company posted $1.82 EPS. The firm's revenue for the quarter was up 7.4% on a year-over-year basis. Equifax has set its Q3 2025 guidance at 1.870-1.970 EPS. FY 2025 guidance at 7.330-7.630 EPS. As a group, sell-side analysts expect that Equifax will post 7.58 EPS for the current fiscal year.

Insider Activity at Equifax

In other news, CEO Mark W. Begor sold 48,264 shares of the business's stock in a transaction on Monday, July 28th. The stock was sold at an average price of $241.71, for a total value of $11,665,891.44. Following the sale, the chief executive officer owned 142,872 shares of the company's stock, valued at approximately $34,533,591.12. The trade was a 25.25% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.40% of the stock is owned by corporate insiders.

Institutional Trading of Equifax

A number of hedge funds have recently modified their holdings of EFX. Texas Capital Bank Wealth Management Services Inc grew its position in Equifax by 3.7% during the first quarter. Texas Capital Bank Wealth Management Services Inc now owns 1,134 shares of the credit services provider's stock valued at $276,000 after purchasing an additional 40 shares in the last quarter. CX Institutional increased its stake in shares of Equifax by 0.9% in the second quarter. CX Institutional now owns 5,005 shares of the credit services provider's stock worth $1,298,000 after acquiring an additional 43 shares during the last quarter. Integrated Advisors Network LLC increased its stake in shares of Equifax by 2.8% in the fourth quarter. Integrated Advisors Network LLC now owns 1,595 shares of the credit services provider's stock worth $406,000 after acquiring an additional 44 shares during the last quarter. Accretive Wealth Partners LLC raised its holdings in shares of Equifax by 1.1% during the second quarter. Accretive Wealth Partners LLC now owns 4,564 shares of the credit services provider's stock worth $1,184,000 after acquiring an additional 48 shares in the last quarter. Finally, Axxcess Wealth Management LLC boosted its position in Equifax by 3.8% during the first quarter. Axxcess Wealth Management LLC now owns 1,395 shares of the credit services provider's stock valued at $340,000 after purchasing an additional 51 shares during the last quarter. Hedge funds and other institutional investors own 96.20% of the company's stock.

About Equifax

(Get Free Report)

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.

Featured Articles

Analyst Recommendations for Equifax (NYSE:EFX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Equifax Right Now?

Before you consider Equifax, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.

While Equifax currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.